Pathology-guided multimodal transformer predicts postoperative survival benefit from adjuvant chemotherapy in glioma: from DNA damage repair to immune characterization
High-grade gliomas (HGGs) are aggressive primary brain tumors with high recurrence rates and poor prognosis. Survival benefit from adjuvant temozolomide (TMZ) varies substantially across patients, and reliable preoperative biomarkers for treatment stratification remain limited. This study aims to develop an interpr...